PAPER
Chemoenzymatic Synthesis of All Four Cytoxazone Stereoisomers
1991
Methyl 4-(4-Methoxyphenyl)-2-oxo-1,3-oxazolidine-5-carb-
oxylate [( )-4]
HRMS: m/z calcd. for C12H13NO5 [M+]: 252.0866. Found:
252.0792.
Azido-ester ( )-3 (6.0 g, 16 mmol) and Ph3P (12.6 g, 48 mmol) were
dissolved in THF (160 mL) and H2O (3.3 mL). The reaction mixture
was heated at 50 °C for 1.5 h. Evolution of N2 was observed during
the first 30 min of the reaction. The solvent was evaporated, the sol-
id residue was dissolved in EtOAc (150 mL), washed with 5% NaCl
(3 50 mL), and dried. Crude product was crystallized from i-Pr2O
to obtain 3.55 g (88%) of oxazolidinone ( )-4, which was 98% pure
by HPLC.
5-epi-5-(Hydroxymethyl)-4-(4-methoxyphenyl)-1,3-oxazolidin-
2-one [( )-8]
5-epi-Cytoxazone [( )-8] was obtained in 82% yield, as described
for ( )-5.
Mp 158–159 °C.
IR (KBr): 3290, 2920, 1720, 1510, 1240, 1025, 830 cm–1.
1H NMR (CD3OD): = 3.39 (br s, 1 H), 3.77 (dd, 1 H, J = 12.0, 3.0
Hz), 3.88 (s, 3 H), 3.90 (dd, 1 H, J = 12.0, 3.0 Hz), 4.35–4.45 (m, 1
H), 4.83 (d, 1 H, J = 6.5 Hz), 7.05 (d, 2 H, J = 8.5 Hz), 7.39 (d, 2 H,
J = 8.5 Hz).
13C NMR (CD3OD): = 55.9, 58.7, 62.6, 87.0, 115.5, 128.7, 133.7,
161.0, 161.5.
Mp 160–161 °C.
IR (KBr): 3240, 2945, 1745, 1720, 1510, 1460, 1215, 1090 cm–1.
1H NMR (CDCl3): = 3.39 (s, 3 H), 3.80 (s, 3 H), 5.19 (d, 1 H,
J = 9.0 Hz), 5.26 (d, 1 H, J = 9.0 Hz), 6.21 (br s, 1 H), 6.87 (d, 2 H,
J = 8.5 Hz), 7.21 (d, 2 H, J = 8.5 Hz).
13C NMR (CDCl3): = 51.9, 55.2, 57.8, 78.0, 113.9, 128.0, 128.5,
158.1, 160.1, 166.7.
Preparative Kinetic Resolution of [( )-5] Catalyzed by Lipase
from Penicillium camembertii
HRMS: m/z calcd. for C12H13NO5 [M+]: 252.0866. Found:
To the solution of ( )-5 (200 mg) in vinyl acetate (140 mL), lipase
from PcamL (4.0 g) was added. The reaction was performed in a
thermostated shaker at 30 °C and 220 rpm. After 9 days, at 50.7%
conversion, the reaction mixture was filtered. The filtrate was evap-
orated and products were separated on a silica gel column (EtOAc–
CH2Cl2, 3:1). Combined fractions yielded pure (+)-5 (81 mg, 89.3%
ee) and (–)-6 (92 mg, 88.2% ee). Acetate (–)-6 was hydrolysed with
KOH/MeOH (1.1 mol equiv of KOH) at r.t. Upon crystallization
from MTBE, (–)-5 was obtained in 99.0% ee, and (+)-5 in 95.2% ee.
252.0811.
5-(Hydroxymethyl)-4-(4-methoxyphenyl)-1,3-oxazolidin-2-one
[( )-5]
Oxazolidinone ( )-4 (50 mg, 0.22 mmol) was dissolved in absolute
EtOH (4 mL), CaCl2 (50 mg, 0.45 mmol) and NaBH4 (40 mg, 1.0
mmol) was added, and reaction mixture was stirred for 20 min at r.t.
The excess of reducing agent was destroyed by the addition of sat.
NH4Cl (0.5 mL), EtOH was evaporated; the residue was dissolved
in EtOAc (30 mL), washed with 5% NaCl (2 20 mL), and dried.
Crude product was crystallized from t-butyl methyl ether (MTBE)–
MeOH (95:5) to give 35 mg (79%) of ( )-5, which was >99% pure
by HPLC.
(–)-5
Mp 122–123 °C (Lit.3 mp 122–123 °C).
[ ]D25 –74.0 (c 0.5, MeOH) [Lit.3 [ ]D –75.7 (c 1.00, MeOH)].
(+)-5
Mp 143–144 °C.
[ ]D25 +70.1 (c 0.5, MeOH).
IR (KBr): 3350, 3240, 2940, 1720, 1215, 1025, 965 cm–1.
1H NMR (acetone-d6): = 3.15–3.26 (m, 3 H), 3.80 (s, 3 H), 4.82
(ddd, 1 H), 5.03 (d, 1 H, J = 8.0 Hz), 6.94 (d, 2 H, J = 8.5 Hz), 6.96
(br s, 1 H), 7.24 (d, 2 H, J = 8.5 Hz).
(–)-6
[ ]D25 –45.2 (c 1.01, MeOH).
13C NMR (acetone-d6): = 54.9, 57.2, 61.9, 80.8, 113.9, 128.3,
129.6, 158.8, 159.9.
Preparative Kinetic Resolution of [( )-8] Catalyzed by Lipase
from Candida antarctica Immobilised in Sol-Gel-AK
To a solution of ( )-8 (157 mg) in vinyl acetate (220 mL), lipase
from CAL in SOL-Gel-AK (455 mg) was added. Using the same
conditions and isolation procedure as described for ( )-5, pure alco-
hol (–)-8 (68 mg, 84.2% ee), and acetyl derivative (+)-9 (90 mg,
87.3% ee) were obtained. Acetyl derivative (+)-9 was hydrolyzed
with KOH–MeOH (1.1 equiv) at r.t. affording 58 mg of (+)-8
(79.1% ee). Upon crystallization from MTBE, both enantiomers
were obtained with >96% ee.
Methyl 4-(4-Methoxyphenyl)-2-oxo-1,3-oxazolidine-5-carb-
oxylate [( )-7]
To a solution of ( )-4 (1.30 g, 5.1 mmol) in EtOH (6 mL), KOH
(320 mg, 5.7 mmol) was added. The resulting mixture was kept at
reflux for 1 h, then cooled to r.t., acidified with 10% HCl, and ex-
tracted with EtOAc (3 30 mL). Combined extracts were washed
with H2O (30 mL), dried (Na2SO4), and evaporated in vacuo. The
residue was dissolved in DMF (15 mL), K2CO3 (700 mg, 5.1 mmol)
and MeI (980 mg, 7.0 mmol) were added. The reaction mixture was
stirred overnight at r.t., then H2O (30 mL) and EtOAc (60 mL) were
added. The organic layer was successively washed with H2O
(5 30 mL), dried, and evaporated. Crude product was purified by
silica gel chromatography (MTBE–hexane, 4:1). Evaporation of the
fractions with ( )-7 afforded 530 mg (46%) of pure product (>99%
by HPLC).
(–)-8
Mp 160–161 °C (Lit.3 mp 161.5–162.5 °C).
[ ]D25 –29.7 (c 1.32, MeOH) [Lit.3 [ ]D –30.4 (c 1.01, MeOH)].
(+)-8
Mp 159–160 °C.
[ ]D25 +28.8 (c 0.59, MeOH).
(+)-9
Mp 123–124 °C.
[ ]D25 +42.7 (c 1.68, MeOH).
IR (KBr): 3270, 2960, 1760, 1710, 1515, 1255, 1205, 1090, 920,
835 cm–1.
1H NMR (CDCl3): = 3.81 (s, 3 H), 3.86 (s, 3 H), 4.72 (d, 1 H,
J = 5.2 Hz), 4.93 (d, 1 H, J = 5.2 Hz), 6.60 (br s, 1 H), 6.92 (d, 2 H,
J = 8.1 Hz), 7.28 (d, 2 H, J = 8.1 Hz).
13C NMR (CDCl3): = 52.9, 55.2, 58.6, 80.3, 114.4, 127.1, 130.6,
157.8, 159.9, 168.7.
Acknowledgement
This work was completed within a collaboration project with PLI-
VA Co., Zagreb.
Synthesis 2001, No. 13, 1989–1992 ISSN 0039-7881 © Thieme Stuttgart · New York